Trenchant Technologies Capital Corp.
Research Trenchant Technologies Capital Corp. (5730) on Bullrun: market cap EUR 2.63M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker5730
- ExchangeF
- CountryCanada
- SectorFinancial Services
- IndustryAsset Management
- CurrencyEUR
- Market capEUR 2.63M
- Financial periodFY2025
- RevenueCAD 0
- Net income-CAD 5.20M
- Free cash flowCAD 185.59K
Valuation Snapshot
latest market cap is EUR 2.63M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 0 | -CAD 5.20M | CAD 185.59K | n/a | n/a | CAD 52.66K | CAD 1.01M | CAD 1.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 2.63M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Trenchant Technologies Capital Corp.
Trenchant Technologies Capital Corp. is a private equity and venture capital firm specializing in early-stage, turnaround, special situation debt financing in private equity companies. The firm prefers to invest in novel technologies including Artificial Intelligence, Quantum Computing, and traditional businesses primarily in the medical, biomedical, and technology sectors. It seeks to invest in Canada.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is Trenchant Technologies Capital Corp.'s market cap?
Trenchant Technologies Capital Corp.'s market capitalization is EUR 2.63M.
What does Trenchant Technologies Capital Corp. do?
Trenchant Technologies Capital Corp. is a private equity and venture capital firm specializing in early-stage, turnaround, special situation debt financing in private equity companies. The firm prefers to invest in novel technologies including Artificial Intelligence, Quantum Computing, and traditional businesses primarily in the medical, biomedical, and technology sectors. It seeks to invest in Canada. It invests in companies that are financially sound, with minimal debt and a clear pathway to significant revenue generation. The company was formerly known as Trenchant Capital Corp.